[go: up one dir, main page]

PE20020557A1 - Uso de agonistas selectivos del receptor de dopamina d4 para tratar la disfuncion sexual - Google Patents

Uso de agonistas selectivos del receptor de dopamina d4 para tratar la disfuncion sexual

Info

Publication number
PE20020557A1
PE20020557A1 PE2001001164A PE2001001164A PE20020557A1 PE 20020557 A1 PE20020557 A1 PE 20020557A1 PE 2001001164 A PE2001001164 A PE 2001001164A PE 2001001164 A PE2001001164 A PE 2001001164A PE 20020557 A1 PE20020557 A1 PE 20020557A1
Authority
PE
Peru
Prior art keywords
sexual dysfunction
receptor agonists
dopamine
receptor
selective dopamine
Prior art date
Application number
PE2001001164A
Other languages
English (en)
Inventor
Jorge D Brioni
Teodozyj Kolasa
Gin C Hsieh
Diana L Donnelly-Roberts
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27109879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20020557(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/985,974 external-priority patent/US20020103105A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20020557A1 publication Critical patent/PE20020557A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE AL USO DE UN AGONISTA DEL RECEPTOR DE DOPAMINA D4 CON LA SALVEDAD QUE DICHO AGONISTA NO SEA 5,6,6a-7-TETRAHIDRO-6-METIL-4H-DIBENZO[de,g]QUINOLINA-10,11-DIOL. EL AGONISTA DEL RECEPTOR DE DOPAMINA D4 SE SELECCIONA DE N-{[4-(2-CIANOFENIL)-1-PIPERAZINIL]METIL}-3-METILBENZAMIDA, 5-FLUORO-2-{[4-(2-PIRIDINIL)-1-PIPERAZINIL]METIL}-1H-INDOL DONDE DICHO AGONISTA DE DOPAMINA ES MAS SELECTIVO POR EL RECEPTOR D4 QUE POR EL RECEPTOR D2. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA UTIL PARA EL TRATAMIENTO DE UNA DISFUNCION SEXUAL
PE2001001164A 2000-11-22 2001-11-21 Uso de agonistas selectivos del receptor de dopamina d4 para tratar la disfuncion sexual PE20020557A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71831100A 2000-11-22 2000-11-22
US09/985,974 US20020103105A1 (en) 2000-11-22 2001-11-07 Use of selective dopamine D4 receptor agonists for treating sexual dysfunction

Publications (1)

Publication Number Publication Date
PE20020557A1 true PE20020557A1 (es) 2002-06-25

Family

ID=27109879

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001164A PE20020557A1 (es) 2000-11-22 2001-11-21 Uso de agonistas selectivos del receptor de dopamina d4 para tratar la disfuncion sexual

Country Status (24)

Country Link
EP (1) EP1345608B1 (es)
JP (1) JP2004534725A (es)
KR (1) KR20030051857A (es)
CN (1) CN1531434A (es)
AR (1) AR035600A1 (es)
AT (1) ATE358483T1 (es)
AU (2) AU2689502A (es)
BG (1) BG107810A (es)
BR (1) BR0110450A (es)
CA (1) CA2429383A1 (es)
CZ (1) CZ20031458A3 (es)
DE (1) DE60127712T2 (es)
ES (1) ES2284727T3 (es)
HU (1) HUP0402358A3 (es)
IL (1) IL155094A0 (es)
MX (1) MXPA03004547A (es)
NO (1) NO20032304L (es)
NZ (1) NZ525086A (es)
PE (1) PE20020557A1 (es)
PL (1) PL365890A1 (es)
SK (1) SK7242003A3 (es)
TW (1) TWI293254B (es)
UY (1) UY27031A1 (es)
WO (1) WO2002041894A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
JP2005531571A (ja) * 2002-05-23 2005-10-20 アボット・ラボラトリーズ 性機能不全の治療に有用なアセトアミド類およびベンズアミド類
WO2007014929A1 (en) 2005-08-03 2007-02-08 Boehringer Ingelheim International Gmbh Use of flibanserin in the treatment of obesity
JP2009513604A (ja) 2005-10-29 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
BRPI0716439B8 (pt) 2006-08-14 2021-05-25 Boehringer Ingelheim Int sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
BRPI0716436B8 (pt) 2006-08-25 2021-05-25 Boehringer Ingelheim Int sistema de liberação controlada e método para fabricação do mesmo
PE20091188A1 (es) 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
US9353067B2 (en) * 2011-04-10 2016-05-31 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2201105T3 (es) * 1994-08-05 2004-03-16 Pfizer Inc. Derivados del bencimidazol con actividad dopaminergica.
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
EP0982030A3 (en) * 1998-08-17 2000-05-10 Pfizer Products Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
US6291471B1 (en) * 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males

Also Published As

Publication number Publication date
JP2004534725A (ja) 2004-11-18
NO20032304D0 (no) 2003-05-21
BG107810A (bg) 2004-02-27
IL155094A0 (en) 2003-10-31
CN1531434A (zh) 2004-09-22
HUP0402358A2 (hu) 2005-03-29
WO2002041894A2 (en) 2002-05-30
AU2002226895B2 (en) 2006-10-12
HK1059884A1 (en) 2004-07-23
PL365890A1 (en) 2005-01-10
AU2689502A (en) 2002-06-03
DE60127712D1 (de) 2007-05-16
KR20030051857A (ko) 2003-06-25
DE60127712T2 (de) 2007-12-27
WO2002041894A3 (en) 2002-10-17
ES2284727T3 (es) 2007-11-16
MXPA03004547A (es) 2004-03-26
NO20032304L (no) 2003-07-15
NZ525086A (en) 2006-07-28
CA2429383A1 (en) 2002-05-30
ATE358483T1 (de) 2007-04-15
UY27031A1 (es) 2002-07-31
HUP0402358A3 (en) 2009-08-28
CZ20031458A3 (cs) 2004-02-18
SK7242003A3 (en) 2004-01-08
TWI293254B (en) 2008-02-11
BR0110450A (pt) 2005-02-09
AR035600A1 (es) 2004-06-16
EP1345608B1 (en) 2007-04-04
EP1345608A2 (en) 2003-09-24

Similar Documents

Publication Publication Date Title
ES2192264T3 (es) Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2(1h)-indol-2-ona (=ziprasidona), su preparacion y su uso como antagonista de la dopamina.
CL2004000655A1 (es) Compuestos derivados de piperidin-2-ona 1,6-disustituidos, sus sales, composicion farmaceutica, agonistas del receptor ep4; uso de los compuestos para tratar hipertension ocular, glaucoma.
CO5690568A2 (es) Agonismo del receptor de 5ht2a para el tratamiento de disfun cion termorreguladora
PE20020557A1 (es) Uso de agonistas selectivos del receptor de dopamina d4 para tratar la disfuncion sexual
ATE435206T1 (de) Heteroarylsulfonylstilbene als 5-ht2a- antagonisten
MY141559A (en) Triazole derivatives as tachykinin receptor antagonists
PE20010683A1 (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
EA200400337A1 (ru) Применение модулятора рецепторов глюкокортикоидов и агониста рецепторов глюкокортикоидов при получении лекарственного средства
DE60120748D1 (de) 3-substituierte oxindolderivate als beta-3-agonisten
NZ525700A (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
CL2008003789A1 (es) Compuestos derivados de bencimidazol sustituido por carboxilo o por hidroxilo, moduladores selectivos del receptor x de farnesoide (fxr); proceso de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la diabetes, dislipidemia, sindrome metabolico, cancer, alzheimer.
PE20120578A1 (es) Agonistas y antagonistas del receptor de s1p5, y metodos de uso de los mismos
MX2007005205A (es) Compuestos biciclicos sulfonilo-sustituidos como moduladores de receptores activados por el proliferador de la peroxisoma.
CL2004000643A1 (es) Composicion farmaceutica que comprende un agonista de 5-ht 1b/1d y un inhibidor selectivo de ciclooxigenasa-2, util en el tratamiento de la migrana.
PA8581401A1 (es) Compuestos de imedazopiridina como agonistas del receptor 5-ht4
GT200500309A (es) Derivados de sulfonilbencilimidazol
AR050407A1 (es) Compuestos quinolinon-carboxamida como agonistas del receptor 5-ht4. procesos de obtencion y composiciones farmaceuticas
CO5580767A2 (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
CY1110443T1 (el) Υποκατεστημενα βενζοπυρανια ως εκλεκτικοι αγωνιστες υποδοχεα-βητα οιστρογονων
NO994850L (no) Farmakologiske midler
PE20010642A1 (es) Combinacion de pramipexol y clonidina para el tratamiento del sindrome de piernas inquietas
AR028579A1 (es) Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinica
UY26601A1 (es) Antagonistas de los receptores de il-8
CY1109694T1 (el) Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης

Legal Events

Date Code Title Description
FC Refusal